SciFluor Life Sciences

About:

SciFluor Life Sciences develops fluorination technologies that improve drug properties such as metabolic stability and potency.

Website: http://www.scifluor.com

Top Investors: Invesco, Allied Minds, Woodford Investment Management

Description:

SciFluor Life Sciences is an Allied Minds funded company with a late-stage fluorination technology that improves drug properties such as metabolic stability, potency, bioavailability, and blood-brain-barrier penetration. The company's late-stage fluorination technology is licensed exclusively from Harvard University. SciFluor's technology enables end-stage or any-stage fluorination of a wide variety of organic compounds.

Total Funding Amount:

$35M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Boston, Massachusetts, United States

Founded Date:

2011-01-01

Founders:

Takeru Furuya, Tobias Ritter

Number of Employees:

1-10

Last Funding Date:

2015-04-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai